Compare UBC Medical Indonesia Tbk. (LABS) vs Siloam International Hospitals Tbk. (SILO) Price & Performance

UBC Medical Indonesia Tbk.Trade

Siloam International Hospitals Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Siloam International Hospitals Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume), while Siloam International Hospitals Tbk. trades at Rp2,320 (market cap 31.21T, 932.2K 24h volume). The key difference: Siloam International Hospitals Tbk. is far larger — about 49.1× UBC Medical Indonesia Tbk.'s market cap, and Siloam International Hospitals Tbk. is more actively traded (932.2K versus 843K). Which is the better fit depends on your goals.

	LABS	SILO
Market Cap	635.95B	31.21T
Volume	843K	932.2K
Lot	8.43K	9.32K
Turnover	137.6M	2.17B
Average Price	163.22	2,324.1
Value	137.6M	2.17B
Indicative Equilibrium Price	165	2,320
Indicative Equilibrium Volume	246	52

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS

View details →

SILO

View details →

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

About Siloam International Hospitals Tbk.

PT Siloam International Hospitals Tbk (the Company) was established under its original name of PT Sentralindo Wirasta on August 3, 1996. The Company started commercial operations in 2010 after the restructuring of the hospital unit of PT Lippo Karawaci Tbk.